No abstract available
MeSH terms
-
Academic Medical Centers / organization & administration*
-
Advisory Committees / organization & administration*
-
Anticoagulants / adverse effects
-
Anticoagulants / therapeutic use*
-
Benchmarking*
-
Boston
-
Consumer Product Safety
-
Drug Monitoring
-
Evidence-Based Medicine
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use*
-
Guideline Adherence
-
Health Knowledge, Attitudes, Practice
-
Humans
-
Organizational Objectives
-
Outcome and Process Assessment, Health Care*
-
Patient Care Team
-
Patient Education as Topic
-
Practice Guidelines as Topic
-
Program Development
-
Quality Indicators, Health Care*
-
Risk Assessment
-
Treatment Outcome
Substances
-
Anticoagulants
-
Fibrinolytic Agents